RRC
69
-7
COST
37
-4
LB
24
-11
CME
50
-2
RHI
62
8
PFE
50
-8
VRSN
47
-19
CINF
48
3
QRVO
59
-24
CTSH
52
-2
MRK
58
5
MDLZ
46
6
MET
43
3
TRIP
54
-28
ADT
50
-3
TGT
45
-16
CVS
39
-9
TRV
46
-21
STX
78
-7
AIG
50
2
RRC
69
-7
COST
37
-4
LB
24
-11
CME
50
-2
RHI
62
8
PFE
50
-8
VRSN
47
-19
CINF
48
3
QRVO
59
-24
CTSH
52
-2
MRK
58
5
MDLZ
46
6
MET
43
3
TRIP
54
-28
ADT
50
-3
TGT
45
-16
CVS
39
-9
TRV
46
-21
STX
78
-7
AIG
50
2
Financhill
Back

BioVie, Inc. Stock Price Chart

Know when to buy, sell, or hold. Rate Any Stock In Seconds

Get Your Free Stock Analysis Now
Sell
9

BIVI
BioVie, Inc.

Last Price:
$1.13
Seasonality Move:
-0.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Color-coded buy, sell, hold signals make stock decisions simple.

Get Your Free Stock Analysis Now
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIVI is experiencing selling pressure, which indicates risk of future bearish movement.

BioVie, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.22 Sell
20-day SMA: 1.25 Sell
50-day SMA: 1.35 Sell
200-day SMA: 4.59 Sell
8-day EMA: 1.21 Sell
20-day EMA: 1.25 Sell
50-day EMA: 1.4 Sell
200-day EMA: 7.8 Sell

BioVie, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 36.8 Sell
Chaikin Money Flow: -105069 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.18 - 1.3) Sell
Bollinger Bands (100): (1.31 - 1.85) Sell

BioVie, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for BioVie, Inc. Stock

Is BioVie, Inc. Stock a Buy?

  • BioVie, Inc. share price is 1.14 while BIVI 8-day simple moving average is 1.22, which is a Sell signal.
  • The stock price of BIVI is 1.14 while BioVie, Inc. 20-day SMA is 1.25, which makes it a Sell.
  • BioVie, Inc. 50-day simple moving average is 1.35 while BIVI share price is 1.14, making it a Sell technically.
  • BIVI stock price is 1.14 and BioVie, Inc. 200-day simple moving average is 4.59, creating a Sell signal.

BIVI Technical Analysis vs Fundamental Analysis

Sell
9
BioVie, Inc. (BIVI) is a Sell

Is BioVie, Inc. a Buy or a Sell?

  • BioVie, Inc. stock is rated a Sell
    The current BioVie, Inc. [BIVI] share price is $1.14. The Score for BIVI is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.

BioVie, Inc. Stock Info

Market Cap:
2.1M
Price in USD:
1.14
Share Volume:
157.7K

BioVie, Inc. 52-Week Range

52-Week High:
20.40
52-Week Low:
1.10
Sell
9
BioVie, Inc. (BIVI) is a Sell

BioVie, Inc. Share Price Forecast

  • What is the BioVie, Inc. stock price today?
    The BioVie, Inc. stock price is 1.14 USD today.
  • Will BIVI stock go up or go down?
    BioVie, Inc.> share price is forecast to RISE/FALL based on technical indicators
  • Is BioVie, Inc. overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioVie, Inc. is overvalued.

Is BioVie, Inc. Stock a Buy?

  • BioVie, Inc. share price is 1.14 while BIVI 8-day exponential moving average is 1.21, which is a Sell signal.
  • The stock price of BIVI is 1.14 while BioVie, Inc. 20-day EMA is 1.25, which makes it a Sell.
  • BioVie, Inc. 50-day exponential moving average is 1.40 while BIVI share price is 1.14, making it a Sell technically.
  • BIVI stock price is 1.14 and BioVie, Inc. 200-day simple moving average is 7.80, creating a Sell signal.

Fundamental Analysis of BioVie, Inc.

Is BioVie, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.45 per share, and a decrease next year of $0.00 per share.

Technical Analysis of BioVie, Inc.

Should I short BioVie, Inc. stock?

* BioVie, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.